市場調查報告書

氣喘、COPD的全球市場 - 各醫藥品類型 (支氣管擴張藥,抗發炎藥,聯合治療)、疾病的各類型、各流通管道、各地區:市場規模、佔有率、未來展望、機會分析

Asthma & COPD Market, By Drug Type (Bronchodilators, Anti-Inflammatories, Combination Therapies), By Disease Type, By Distribution Channel, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 952827
出版日期 內容資訊 英文 183 Pages
商品交期: 2-3個工作天內
價格
氣喘、COPD的全球市場 - 各醫藥品類型 (支氣管擴張藥,抗發炎藥,聯合治療)、疾病的各類型、各流通管道、各地區:市場規模、佔有率、未來展望、機會分析 Asthma & COPD Market, By Drug Type (Bronchodilators, Anti-Inflammatories, Combination Therapies), By Disease Type, By Distribution Channel, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年07月16日內容資訊: 英文 183 Pages
簡介

本報告提供全球氣喘及COPD (慢性阻塞性肺病)的治療藥的市場相關分析,疾病、產品概要,及市場基本結構及促進、阻礙因素,整體市場規模預測 (過去3年、今後8年份),各醫藥品類型、疾病的各類型、各流通管道、各地區的詳細趨勢,主要企業的簡介、業績、策略計劃等調查。

目錄

第1章 分析目的、前提條件

第2章 市場概要

  • 分析概要
  • 摘要整理
  • COM (Coherent Opportunity Map:市場機會藍圖)

第3章 市場動態、規定、趨勢分析

  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 市場機會
  • 影響度分析
  • 近幾年主要的動向
  • 法規方案
  • PEST分析
  • 新型冠狀病毒感染疾病 (COVID-19)的影響度分析

第4章 全球氣喘、COPD市場:各醫藥品類型

  • 簡介
    • 市場佔有率 (最新值、預測值)
    • 與前一年同期相比成長率 (YoY) (總計11年份)
  • 各部門詳細趨勢
    • 支氣管擴張藥
      • 短時間作用型支氣管擴張藥
      • 長時間作用型支氣管擴張藥
      • 抗膽鹼藥
    • 抗發炎劑
      • 吸入皮質類固醇
      • 抗白三烯
      • 單株抗體
    • 聯合治療

第5章 全球氣喘、COPD市場:疾病的各類型

  • 簡介
    • 市場佔有率 (最新值、預測值)
    • 與前一年同期相比成長率 (YoY) (總計11年份)
  • 各部門詳細趨勢
    • 氣喘
    • COPD (慢性阻塞性肺病)

第6章 全球氣喘、COPD市場:各流通管道

  • 簡介
    • 市場佔有率 (最新值、預測值)
    • 與前一年同期相比成長率 (YoY) (總計11年份)
  • 各部門詳細趨勢
    • 醫院藥局
      • 簡介
      • 市場規模與其預測,與前一年同期相比成長率 (以金額為準,總計11年份)
    • 零售藥局
    • 線上藥局
    • 藥妝店

第7章 全球氣喘、COPD市場:各地區

  • 簡介
    • 市場佔有率 (最新值、預測值)
    • 與前一年同期相比成長率 (YoY) (總計11年份)
  • 各地區的詳細趨勢
    • 北美
      • 美國
      • 加拿大
    • 歐洲
      • 英國
      • 德國
      • 義大利
      • 法國
      • 西班牙
      • 俄羅斯
      • 其他的歐洲各國
    • 亞太地區
      • 中國
      • 印度
      • 日本
      • 東南亞國協
      • 澳洲
      • 韓國
      • 其他的亞太地區各國
    • 南美
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他的南美各國
    • 中東
      • 波灣合作理事會 (GCC) 各國
      • 以色列
      • 其他的中東各國
    • 非洲
      • 北部非洲
      • 中部非洲
      • 非洲南部

第8章 競爭情形

  • 企業簡介
    • AstraZeneca PLC
    • Novartis AG
    • GlaxoSmithKline plc
    • Merck & Co., Inc.
    • Verona Pharma plc
    • Regeneron Pharmaceuticals, Inc.
    • Boehringer Ingelheim GmbH

第9章 附錄

目錄

Asthma is a type of chronic respiratory disease, which is characterized by attacks of breathlessness and wheezing. Asthma can occur at any stage, though it is the most common disease in children. Asthma attacks are linked to respiratory infections and environmental factors such as allergens, tobacco, smoke, and indoor and outdoor pollution. Indoor pollution factors include mold, chemicals, strong odors, and house dust whereas outdoor pollution factors include air pollution, allergens, tobacco, and smoking. Such factors are responsible for development and exacerbation of asthma.

Restraints of the Global Asthma and COPD Market

Major factors hampering the growth of the asthma and COPD market during the forecast period constitutes of patent losses, and high costs.

Key features of the study:

  • This report provides in-depth analysis of the global asthma and COPD market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global asthma and COPD market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include AstraZeneca, Novartis AG, GlaxoSmithKline plc, Merck & Co., Verona Pharma plc,, Regeneron Pharmaceuticals, Inc., GlaxoSmithKline plc, and Boehringer Ingelheim GmbH.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global asthma and COPD market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Asthma and COPD Market, By Drug Type:
    • Bronchodilators
  • Short Acting Bronchodilators
  • Long Acting Bronchodilators
  • Anticholinergics
    • Anti-Inflammatories
  • Inhaled Corticosteroids
  • Anti-Leukotriene
  • Monoclonal Antibodies
    • Combination Therapies
  • Global Asthma and COPD Market, By Disease Type:
    • Asthma
    • COPD
  • Global Asthma and COPD Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Drug Stores
  • Global Asthma and COPD Market, By Geography:
    • North America
  • By Drug Type
    • Bronchodilators
      • Short Acting Bronchodilators
      • Long Acting Bronchodilators
      • Anticholinergics
    • Anti-Inflammatories
      • Inhaled Corticosteroids
      • Anti-Leukotriene
      • Monoclonal Antibodies
    • Combination Therapies
  • By Disease Type
    • Asthma
    • COPD
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Drug Stores
  • By Country:
    • U.S.
    • Canada
    • Europe
  • By Drug Type
    • Bronchodilators
      • Short Acting Bronchodilators
      • Long Acting Bronchodilators
      • Anticholinergics
    • Anti-Inflammatories
      • Inhaled Corticosteroids
      • Anti-Leukotriene
      • Monoclonal Antibodies
    • Combination Therapies
  • By Disease Type
    • Asthma
    • COPD
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Drug Stores
  • By Country:
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • By Drug Type
    • Bronchodilators
      • Short Acting Bronchodilators
      • Long Acting Bronchodilators
      • Anticholinergics
    • Anti-Inflammatories
      • Inhaled Corticosteroids
      • Anti-Leukotriene
      • Monoclonal Antibodies
    • Combination Therapies
  • By Disease Type
    • Asthma
    • COPD
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Drug Stores
  • By Country:
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • By Drug Type
    • Bronchodilators
      • Short Acting Bronchodilators
      • Long Acting Bronchodilators
      • Anticholinergics
    • Anti-Inflammatories
      • Inhaled Corticosteroids
      • Anti-Leukotriene
      • Monoclonal Antibodies
    • Combination Therapies
  • By Disease Type
    • Asthma
    • COPD
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Drug Stores
  • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East:
  • By Drug Type
    • Bronchodilators
      • Short Acting Bronchodilators
      • Long Acting Bronchodilators
      • Anticholinergics
    • Anti-Inflammatories
      • Inhaled Corticosteroids
      • Anti-Leukotriene
      • Monoclonal Antibodies
    • Combination Therapies
  • By Disease Type
    • Asthma
    • COPD
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Drug Stores
  • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • By Drug Type
    • Bronchodilators
      • Short Acting Bronchodilators
      • Long Acting Bronchodilators
      • Anticholinergics
    • Anti-Inflammatories
      • Inhaled Corticosteroids
      • Anti-Leukotriene
      • Monoclonal Antibodies
    • Combination Therapies
  • By Disease Type
    • Asthma
    • COPD
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Drug Stores
  • By Country/Region:
    • Central Africa
    • South Africa
    • North Africa
  • Company Profiles
    • AstraZeneca PLC*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
    • Novartis AG
    • GlaxoSmithKline plc
    • Merck & Co., Inc.
    • Verona Pharma plc
    • Regeneron Pharmaceuticals, Inc.
    • Boehringer Ingelheim GmbH

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
  • Market Definition and Scope
    • Executive Summary
  • Market Snippet, By Drug Type
  • Market Snippet, By Disease Type
  • Market Snippet, By Distribution Channel
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis
    • COVID-19 Impact Analysis

4. Global Asthma and COPD Market, By Drug Type, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Bronchodilators
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Short Acting Bronchodilators
    • Long Acting Bronchodilators
    • Anticholinergics
    • Anti-Inflammatories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Inhaled Corticosteroids
    • Anti-Leukotriene
    • Monoclonal Antibodies
    • Combination Therapies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends

5. Global Asthma and COPD Market, By Disease Type, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Asthma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • COPD
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Asthma and COPD Market, By Distribution Channel, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Drug Stores
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global Asthma and COPD Market, By Regions, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
    • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

    • Company Profiles
  • AstraZeneca PLC
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis AG
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlaxoSmithKline plc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co., Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Verona Pharma plc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Regeneron Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boehringer Ingelheim GmbH
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

    • References
    • Research Methodology
    • About us and Sales Contact